TreeWAS – Variant ID: rs1446682

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
M23.36 Other meniscus derangements (Other and unspecified lateral meniscus)	0.000	0.957	0.043
C90.0 Multiple myeloma	0.000	0.980	0.020
R26.2 Difficulty in walking, not elsewhere classified	0.000	0.984	0.016
N64.9 Disorder of breast, unspecified	0.015	0.985	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.000	0.988	0.012
R26.8 Other and unspecified abnormalities of gait and mobility	0.000	0.988	0.012
R26 Abnormalities of gait and mobility	0.000	0.988	0.011
Y86 Sequelae of other accidents	0.011	0.989	0.000
C90.2 Plasmacytoma, extramedullary	0.000	0.989	0.011
O46.9 Antepartum haemorrhage, unspecified	0.000	0.991	0.009
C90.1 Plasma cell leukaemia	0.000	0.991	0.009
R26.3 Immobility	0.000	0.991	0.009
R26.1 Paralytic gait	0.000	0.991	0.008
C90.3 Solitary plasmacytoma	0.000	0.992	0.008
N64 Other disorders of breast	0.008	0.992	0.000
M23.3 Other meniscus derangements	0.000	0.992	0.008
N64.4 Mastodynia	0.007	0.993	0.000
F45.8 Other somatoform disorders	0.007	0.993	0.000
S92.00 Fracture of calcaneus (closed)	0.007	0.993	0.000
M23.33 Other meniscus derangements (Medial collateral ligament or Other and unspecified medial meniscus)	0.000	0.993	0.007
R26.0 Ataxic gait	0.000	0.993	0.006
N64.5 Other signs and symptoms in breast	0.006	0.994	0.000
N64.3 Galactorrhoea not associated with childbirth	0.006	0.994	0.000
N64.2 Atrophy of breast	0.006	0.994	0.000
N64.0 Fissure and fistula of nipple	0.006	0.994	0.000
M23.37 Other meniscus derangements-Capsular lig	0.000	0.994	0.006
S92.0 Fracture of calcaneus	0.006	0.994	0.000
M23.32 Other meniscus derangements (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.000	0.994	0.006
M23.31 Other meniscus derangements (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.000	0.994	0.005
M23.35 Other meniscus derangements (Posterior horn of lateral meniscus)	0.000	0.995	0.005
M23.34 Other meniscus derangements (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.000	0.995	0.005
N64.8 Other specified disorders of breast	0.005	0.995	0.000
S92 Fracture of foot, except ankle	0.005	0.995	0.000
O46 Antepartum haemorrhage, not elsewhere classified	0.000	0.995	0.005
Z93.1 Gastrostomy status	0.000	0.995	0.005
S92.5 Fracture of other toe	0.005	0.995	0.000
K51.8 Other ulcerative colitis	0.000	0.995	0.005
S92.50 Fracture of other toe (closed)	0.005	0.995	0.000
N64.1 Fat necrosis of breast	0.005	0.995	0.000
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.005	0.995	0.000
S92.01 Fracture of calcaneus (open)	0.004	0.996	0.000
O46.8 Other antepartum haemorrhage	0.000	0.996	0.004
S92.7 Multiple fractures of foot	0.004	0.996	0.000
S92.1 Fracture of talus	0.004	0.996	0.000
M23.39 Other meniscus derangements (Unspecified ligament or Unspecified meniscus)	0.000	0.996	0.004
S92.51 Fracture of other toe (open)	0.004	0.996	0.000
R59.1 Generalised enlarged lymph nodes	0.000	0.996	0.004
S92.9 Fracture of foot, unspecified	0.004	0.996	0.000
O46.0 Antepartum haemorrhage with coagulation defect	0.000	0.996	0.004
T92.2 Sequelae of fracture at wrist and hand level	0.004	0.996	0.000
K51.3 Ulcerative (chronic) rectosigmoiditis	0.000	0.996	0.004
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.004	0.996	0.000
Y88 Sequelae of surgical and medical care as external cause	0.004	0.996	0.000
M23.30 Other meniscus derangements (Multiple sites)	0.000	0.996	0.004
S92.10 Fracture of talus (closed)	0.004	0.996	0.000
S92.70 Multiple fractures of foot (closed)	0.003	0.996	0.000
K51 Ulcerative colitis	0.000	0.996	0.004
S92.4 Fracture of great toe	0.003	0.996	0.000
S92.2 Fracture of other tarsal bone(s)	0.003	0.996	0.000
F45 Somatoform disorders	0.004	0.996	0.000
Y89 Sequelae of other external causes	0.003	0.996	0.000
S92.3 Fracture of metatarsal bone	0.003	0.997	0.000
Y87 Sequelae of intentional self-harm, assault and events of undetermined intent	0.003	0.997	0.000
S91 Open wound of ankle and foot	0.003	0.997	0.000
S92.11 Fracture of talus (open)	0.003	0.997	0.000
S92.71 Multiple fractures of foot (open)	0.003	0.997	0.000
S90.9 Superficial injury of ankle and foot, unspecified	0.003	0.997	0.000
S90-S99 Injuries to the ankle and foot	0.003	0.997	0.000
K51.5 Mucosal proctocolitis	0.000	0.997	0.003
T84.5 Infection and inflammatory reaction due to internal joint prosthesis	0.000	0.997	0.003
S39.9 Unspecified injury of abdomen, lower back and pelvis	0.003	0.997	0.000
K51.0 Ulcerative (chronic) enterocolitis	0.000	0.997	0.003
S06.00 Concussion (without open intracranial wound)	0.003	0.997	0.000
S90 Superficial injury of ankle and foot	0.003	0.997	0.000
T92.0 Sequelae of open wound of upper limb	0.003	0.997	0.000
T92 Sequelae of injuries of upper limb	0.003	0.997	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.000	0.997	0.003
K51.4 Pseudopolyposis of colon	0.000	0.997	0.003
S92.91 Fracture of foot, unspecified (open)	0.003	0.997	0.000
S92.90 Fracture of foot, unspecified (closed)	0.003	0.997	0.000
F45.4 Persistent somatoform pain disorder	0.003	0.997	0.000
F45.3 Somatoform autonomic dysfunction	0.003	0.997	0.000
S92.41 Fracture of great toe (open)	0.003	0.997	0.000
Y88.3 Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient or of later complication, without mention of misadventure at the time of the procedure	0.003	0.997	0.000
R57.2 Septic shock	0.000	0.997	0.003
S91.3 Open wound of other parts of foot	0.003	0.997	0.000
S91.1 Open wound of toe(s) without damage to nail	0.003	0.997	0.000
S91.0 Open wound of ankle	0.003	0.997	0.000
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.000	0.997	0.003
Y88.2 Sequelae of adverse incidents associated with medical devices in diagnostic and therapeutic use	0.003	0.997	0.000
Y88.1 Sequelae of misadventures to patients during surgical and medical procedures	0.003	0.997	0.000
Y88.0 Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use	0.003	0.997	0.000
S92.21 Fracture of other tarsal bone(s) (open)	0.003	0.997	0.000
F00.9 Dementia in Alzheimer's disease, unspecified	0.003	0.997	0.000
F45.2 Hypochondriacal disorder	0.003	0.997	0.000
F45.1 Undifferentiated somatoform disorder	0.003	0.997	0.000
Y89.9 Sequelae of unspecified external cause	0.003	0.997	0.000
F45.9 Somatoform disorder, unspecified	0.003	0.997	0.000
Y89.1 Sequelae of war operations	0.003	0.997	0.000
Y89.0 Sequelae of legal intervention	0.003	0.997	0.000
S92.31 Fracture of metatarsal bone (open)	0.003	0.997	0.000
K51.2 Ulcerative (chronic) proctitis	0.000	0.997	0.003
C91 Lymphoid leukaemia	0.000	0.997	0.003
Y87.0 Sequelae of intentional self-harm	0.003	0.997	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.000	0.997	0.003
T92.3 Sequelae of dislocation, sprain and strain of upper limb	0.003	0.997	0.000
Y87.2 Sequelae of events of undetermined intent	0.003	0.997	0.000
Z01.5 Diagnostic skin and sensitisation tests	0.003	0.997	0.000
Y85 Sequelae of transport accidents	0.003	0.997	0.000
S91.7 Multiple open wounds of ankle and foot	0.003	0.997	0.000
S91.2 Open wound of toe(s) with damage to nail	0.003	0.997	0.000
C93 Monocytic leukaemia	0.000	0.997	0.003
S98 Traumatic amputation of ankle and foot	0.002	0.997	0.000
S95 Injury of blood vessels at ankle and foot level	0.002	0.997	0.000
S94 Injury of nerves at ankle and foot level	0.002	0.997	0.000
F45.0 Somatisation disorder	0.002	0.997	0.000
M96.1 Postlaminectomy syndrome, not elsewhere classified	0.003	0.997	0.000
C88 Malignant immunoproliferative diseases	0.000	0.997	0.003
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
T92.6 Sequelae of crushing injury and traumatic amputation of upper limb	0.002	0.997	0.000
S97 Crushing injury of ankle and foot	0.002	0.997	0.000
S90.0 Contusion of ankle	0.002	0.997	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.000	0.997	0.002
S96 Injury of muscle and tendon at ankle and foot level	0.002	0.997	0.000
S93 Dislocation, sprain and strain of joints and ligaments at ankle and foot level	0.002	0.997	0.000
C91.1 Chronic lymphocytic leukaemia	0.000	0.997	0.003
S90.7 Multiple superficial injuries of ankle and foot	0.002	0.997	0.000
S90.2 Contusion of toe(s) with damage to nail	0.002	0.997	0.000
S90.1 Contusion of toe(s) without damage to nail	0.002	0.997	0.000
S92.20 Fracture of other tarsal bone(s) (closed)	0.002	0.997	0.000
T92.4 Sequelae of injury of nerve of upper limb	0.002	0.997	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.997	0.002
C94 Other leukaemias of specified cell type	0.000	0.997	0.002
C86 Other specified types of T/NK-cell lymphoma	0.000	0.997	0.002
C83 Diffuse non-Hodgkin's lymphoma	0.000	0.997	0.002
C81 Hodgkin's disease	0.000	0.997	0.002
T92.9 Sequelae of unspecified injury of upper limb	0.002	0.998	0.000
Z01.8 Other specified special examinations	0.002	0.998	0.000
T92.1 Sequelae of fracture of arm	0.002	0.998	0.000
M96.8 Other postprocedural musculoskeletal disorders	0.002	0.998	0.000
T92.8 Sequelae of other specified injuries of upper limb	0.002	0.998	0.000
Z01.6 Radiological examination, not elsewhere classified	0.002	0.998	0.000
H72.9 Perforation of tympanic membrane, unspecified	0.002	0.998	0.000
Y87.1 Sequelae of assault	0.002	0.998	0.000
S92.40 Fracture of great toe (closed)	0.002	0.998	0.000
S90.3 Contusion of other and unspecified parts of foot	0.002	0.998	0.000
K51.1 Ulcerative (chronic) ileocolitis	0.000	0.998	0.002
S92.30 Fracture of metatarsal bone (closed)	0.002	0.998	0.000
C84.0 Mycosis fungoides	0.000	0.998	0.002
S90.8 Other superficial injuries of ankle and foot	0.002	0.998	0.000
C81.0 Lymphocytic predominance	0.000	0.998	0.002
C93.1 Chronic monocytic leukaemia	0.000	0.998	0.002
C91.9 Lymphoid leukaemia, unspecified	0.000	0.998	0.002
C91.4 Hairy-cell leukaemia	0.000	0.998	0.002
C91.5 Adult T-cell leukaemia	0.000	0.998	0.002
Y57.9 Drug or medicament, unspecified	0.002	0.998	0.000
C81.9 Hodgkin's disease, unspecified	0.000	0.998	0.002
C82.1 Mixed small cleaved and large cell, follicular	0.000	0.998	0.002
C88.0 Waldenstrom's macroglobulinaemia	0.000	0.998	0.002
C91.8 Mature B-cell leukaemia Burkitt-type	0.000	0.998	0.002
C91.7 Other lymphoid leukaemia	0.000	0.998	0.002
C91.6 Prolymphocytic leukaemia of T-cell type	0.000	0.998	0.002
C91.3 Prolymphocytic leukaemia	0.000	0.998	0.002
C91.2 Subacute lymphocytic leukaemia	0.000	0.998	0.002
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.000	0.998	0.002
Z01 Other special examinations and investigations of persons without complaint or reported diagnosis	0.002	0.998	0.000
C83.7 Burkitt's tumour	0.000	0.998	0.002
T92.5 Sequelae of injury of muscle and tendon of upper limb	0.002	0.998	0.000
S93.3 Dislocation of other and unspecified parts of foot	0.002	0.998	0.000
C84.4 Peripheral T-cell lymphoma	0.000	0.998	0.002
C93.9 Monocytic leukaemia, unspecified	0.000	0.998	0.002
C93.7 Other monocytic leukaemia	0.000	0.998	0.002
C93.3 Juvenile myelomonocytic leukaemia	0.000	0.998	0.002
C93.2 Subacute monocytic leukaemia	0.000	0.998	0.002
C93.0 Acute monocytic leukaemia	0.000	0.998	0.002
I12.9 Hypertensive renal disease without renal failure	0.000	0.998	0.002
S94.9 Injury of unspecified nerve at ankle and foot level	0.002	0.998	0.000
S94.8 Injury of other nerves at ankle and foot level	0.002	0.998	0.000
S94.7 Injury of multiple nerves at ankle and foot level	0.002	0.998	0.000
S94.3 Injury of cutaneous sensory nerve at ankle and foot level	0.002	0.998	0.000
S94.2 Injury of deep peroneal nerve at ankle and foot level	0.002	0.998	0.000
S94.1 Injury of medial plantar nerve	0.002	0.998	0.000
S94.0 Injury of lateral plantar nerve	0.002	0.998	0.000
S95.9 Injury of unspecified blood vessel at ankle and foot level	0.002	0.998	0.000
S95.8 Injury of other blood vessels at ankle and foot level	0.002	0.998	0.000
S95.7 Injury of multiple blood vessels at ankle and foot level	0.002	0.998	0.000
S95.2 Injury of dorsal vein of foot	0.002	0.998	0.000
S95.1 Injury of plantar artery of foot	0.002	0.998	0.000
S95.0 Injury of dorsal artery of foot	0.002	0.998	0.000
S98.4 Traumatic amputation of foot, level unspecified	0.002	0.998	0.000
S98.3 Traumatic amputation of other parts of foot	0.002	0.998	0.000
S98.2 Traumatic amputation of two or more toes	0.002	0.998	0.000
S98.1 Traumatic amputation of one toe	0.002	0.998	0.000
S98.0 Traumatic amputation of foot at ankle level	0.002	0.998	0.000
C82.0 Small cleaved cell, follicular	0.000	0.998	0.002
S93.2 Rupture of ligaments at ankle and foot level	0.002	0.998	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.000	0.998	0.002
C88.7 Other malignant immunoproliferative diseases	0.000	0.998	0.002
C88.3 Immunoproliferative small intestinal disease	0.000	0.998	0.002
C88.2 Gamma heavy chain disease	0.000	0.998	0.002
C88.1 Alpha heavy chain disease	0.000	0.998	0.002
S96.8 Injury of other muscles and tendons at ankle and foot level	0.002	0.998	0.000
N45.9 Orchitis, epididymitis and epididymo-orchitis without abscess	0.000	0.998	0.002
S97.1 Crushing injury of toe(s)	0.002	0.998	0.000
S97.0 Crushing injury of ankle	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
T44.0 Anticholinesterase agents	0.002	0.998	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.000	0.998	0.002
C84.8 Cutaneous T-cell lymphoma, unspecified	0.000	0.998	0.002
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.000	0.998	0.002
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.000	0.998	0.002
C84.3 Lymphoepithelioid lymphoma	0.000	0.998	0.002
C84.2 T-zone lymphoma	0.000	0.998	0.002
C84.1 Sezary's diease	0.000	0.998	0.002
S96.7 Injury of multiple muscles and tendons at ankle and foot level	0.002	0.998	0.000
S96.2 Injury of intrinsic muscle and tendon at ankle and foot level	0.002	0.998	0.000
S96.1 Injury of muscle and tendon of long extensor muscle of toe at ankle and foot level	0.002	0.998	0.000
S96.0 Injury of muscle and tendon of long flexor muscle of toe at ankle and foot level	0.002	0.998	0.000
T45.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
C83.1 Small cleaved cell (diffuse)	0.000	0.998	0.002
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.000	0.998	0.002
S93.4 Sprain and strain of ankle	0.002	0.998	0.000
S93.6 Sprain and strain of other and unspecified parts of foot	0.002	0.998	0.000
S93.5 Sprain and strain of toe(s)	0.002	0.998	0.000
S99 Other and unspecified injuries of ankle and foot	0.002	0.998	0.000
C92 Myeloid leukaemia	0.000	0.998	0.002
C81.7 Other Hodgkin's disease	0.000	0.998	0.002
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.000	0.998	0.002
C81.3 Lymphocytic depletion	0.000	0.998	0.002
C83.6 Undifferentiated (diffuse)	0.000	0.998	0.002
C83.5 Lymphoblastic (diffuse)	0.000	0.998	0.002
C83.4 Immunoblastic (diffuse)	0.000	0.998	0.002
C83.2 Mixed small and large cell (diffuse)	0.000	0.998	0.002
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.000	0.998	0.002
C86.5 Angioimmunoblastic T-cell lymphoma	0.000	0.998	0.002
C86.4 Blastic NK-cell lymphoma	0.000	0.998	0.002
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.000	0.998	0.002
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.000	0.998	0.002
C86.1 Hepatosplenic T-cell lymphoma	0.000	0.998	0.002
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.000	0.998	0.002
C94.7 Other specified leukaemias	0.000	0.998	0.002
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.000	0.998	0.002
C94.5 Acute myelofibrosis	0.000	0.998	0.002
C94.4 Acute panmyelosis	0.000	0.998	0.002
C94.3 Mast cell leukaemia	0.000	0.998	0.002
C94.2 Acute megakaryoblastic leukaemia	0.000	0.998	0.002
C94.1 Chronic erythraemia	0.000	0.998	0.002
C94.0 Acute erythraemia and erythroleukaemia	0.000	0.998	0.002
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.000	0.998	0.002
C96.8 Histiocytic sarcoma	0.000	0.998	0.002
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.998	0.002
C96.6 Unifocal Langerhans-cell histiocytosis	0.000	0.998	0.002
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.000	0.998	0.002
C96.4 Sarcoma of dendritic cells (accessory cells)	0.000	0.998	0.002
C96.3 True histiocytic lymphoma	0.000	0.998	0.002
C96.2 Malignant mast cell tumour	0.000	0.998	0.002
C96.1 Malignant histiocytosis	0.000	0.998	0.002
C96.0 Letterer-Siwe disease	0.000	0.998	0.002
S97.8 Crushing injury of other parts of ankle and foot	0.002	0.998	0.000
C95 Leukaemia of unspecified cell type	0.000	0.998	0.002
T88.6 Anaphylactic shock due to adverse effect of correct drug or medicament properly administered	0.002	0.998	0.000
R06.6 Hiccough	0.000	0.998	0.002
S93.1 Dislocation of toe(s)	0.002	0.998	0.000
F00 Dementia in Alzheimer's disease	0.002	0.998	0.000
C92.0 Acute myeloid leukaemia	0.000	0.998	0.002
F00.0 Dementia in Alzheimer's disease with early onset	0.002	0.998	0.000
Y85.0 Sequelae of motor-vehicle accident	0.002	0.998	0.000
Z01.4 Gynaecological examination (general)(routine)	0.002	0.998	0.000
C81.2 Mixed cellularity	0.000	0.998	0.002
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.000	0.998	0.002
C91.0 Acute lymphoblastic leukaemia	0.000	0.998	0.002
C82.3 Follicular lymphoma grade IIIa	0.000	0.998	0.002
S96.9 Injury of unspecified muscle and tendon at ankle and foot level	0.002	0.998	0.000
C82.6 Cutaneous follicle centre lymphoma	0.000	0.998	0.002
C82.5 Diffuse follicle centre lymphoma	0.000	0.998	0.002
T91.2 Sequelae of other fracture of thorax and pelvis	0.002	0.998	0.000
K51.9 Ulcerative colitis, unspecified	0.000	0.998	0.002
Z01.3 Examination of blood pressure	0.002	0.998	0.000
Z01.1 Examination of ears and hearing	0.002	0.998	0.000
Z01.0 Examination of eyes and vision	0.002	0.998	0.000
R82.9 Other and unspecified abnormal finding in urine	0.002	0.998	0.000
S70.9 Superficial injury of hip and thigh, unspecified	0.002	0.998	0.000
S39 Other and unspecified injuries of abdomen, lower back and pelvis	0.002	0.998	0.000
S93.0 Dislocation of ankle joint	0.002	0.998	0.000
M86.97 Osteomyelitis, unspecified (Ankle and foot)	0.000	0.998	0.002
Z01.9 Special examination, unspecified	0.002	0.998	0.000
C82.4 Follicular lymphoma grade IIIb	0.000	0.998	0.002
F00.1 Dementia in Alzheimer's disease with late onset	0.002	0.998	0.000
H55 Nystagmus and other irregular eye movements	0.000	0.998	0.002
S93.40 Sprain of unspecified ligament of ankle	0.002	0.998	0.000
O82.0 Delivery by elective Caesarean section	0.000	0.998	0.002
T36.0 Penicillins	0.002	0.998	0.000
C82.2 Large cell, follicular	0.000	0.998	0.002
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.000	0.998	0.002
C92.7 Other myeloid leukaemia	0.000	0.998	0.002
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.000	0.998	0.002
C92.5 Acute myelomonocytic leukaemia	0.000	0.998	0.002
C92.3 Myeloid sarcoma	0.000	0.998	0.002
C92.2 Subacute myeloid leukaemia	0.000	0.998	0.002
S99.7 Multiple injuries of ankle and foot	0.001	0.998	0.000
H53.1 Subjective visual disturbances	0.002	0.998	0.000
C84.5 Other and unspecified T-cell lymphomas	0.000	0.998	0.002
C95.7 Other leukaemia of unspecified cell type	0.000	0.998	0.001
C95.2 Subacute leukaemia of unspecified cell type	0.000	0.998	0.001
C95.0 Acute leukaemia of unspecified cell type	0.000	0.998	0.001
N32.0 Bladder-neck obstruction	0.002	0.998	0.000
S99.8 Other specified injuries of ankle and foot	0.001	0.998	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
C92.4 Acute promyelocytic leukaemia	0.000	0.998	0.002
T91.3 Sequelae of injury of spinal cord	0.002	0.998	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.002	0.998	0.000
S32.40 Fracture of acetabulum (closed)	0.002	0.998	0.000
X41.9 Unspecified place	0.002	0.998	0.000
Z01.2 Dental examination	0.002	0.998	0.000
M96 Postprocedural musculoskeletal disorders, not elsewhere classified	0.002	0.998	0.000
T36 Poisoning by systemic antibiotics	0.002	0.998	0.000
M86.96 Osteomyelitis, unspecified (Lower leg)	0.000	0.998	0.002
F00.2 Dementia in Alzheimer's disease, atypical or mixed type	0.002	0.998	0.000
T39.0 Salicylates	0.002	0.998	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.002	0.998	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
T91 Sequelae of injuries of neck and trunk	0.002	0.998	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.002	0.998	0.000
C92.9 Myeloid leukaemia, unspecified	0.000	0.998	0.001
R09.1 Pleurisy	0.002	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.002	0.998	0.000
T46.1 Calcium-channel blockers	0.002	0.998	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.000	0.998	0.001
V48.4 Person injured while boarding or alighting	0.000	0.998	0.002
G30.9 Alzheimer's disease, unspecified	0.002	0.998	0.000
K62.6 Ulcer of anus and rectum	0.002	0.998	0.000
S06.0 Concussion	0.002	0.998	0.000
S39.7 Other multiple injuries of abdomen, lower back and pelvis	0.001	0.998	0.000
S39.6 Injury of intra-abdominal organ(s) with pelvic organ(s)	0.001	0.998	0.000
T38.0 Glucocorticoids and synthetic analogues	0.001	0.998	0.000
M15.1 Heberden's nodes (with arthropathy)	0.002	0.998	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.001	0.998	0.000
S39.8 Other specified injuries of abdomen, lower back and pelvis	0.001	0.998	0.000
T91.1 Sequelae of fracture of spine	0.002	0.998	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.001	0.998	0.000
C81.1 Nodular sclerosis	0.000	0.998	0.001
C83.0 Small cell (diffuse)	0.000	0.998	0.001
F12.1 Harmful use	0.002	0.998	0.000
Y85.9 Sequelae of other and unspecified transport accidents	0.001	0.998	0.000
S39.0 Injury of muscle and tendon of abdomen, lower back and pelvis	0.001	0.998	0.000
T39.1 4-Aminophenol derivatives	0.002	0.998	0.000
Y73.2 Prosthetic and other implants, materials and accessory devices	0.001	0.998	0.000
I72.4 Aneurysm of artery of lower extremity	0.002	0.998	0.000
I74.5 Embolism and thrombosis of iliac artery	0.002	0.998	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.000	0.998	0.001
D02.0 Larynx	0.000	0.998	0.001
M96.6 Fracture of bone following insertion of orthopaedic implant, joint prosthesis or bone plate	0.001	0.998	0.000
M96.5 Postradiation scoliosis	0.001	0.998	0.000
M96.4 Postsurgical lordosis	0.001	0.998	0.000
M96.3 Postlaminectomy kyphosis	0.001	0.998	0.000
M96.2 Postradiation kyphosis	0.001	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.001	0.998	0.000
T36.8 Other systemic antibiotics	0.001	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.001	0.998	0.000
T36.6 Rifamycins	0.001	0.998	0.000
T36.5 Aminoglycosides	0.001	0.998	0.000
T36.4 Tetracyclines	0.001	0.998	0.000
T36.3 Macrolides	0.001	0.998	0.000
T36.2 Chloramphenicol group	0.001	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.001	0.998	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.001	0.998	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.001	0.998	0.000
T45.8 Other primarily systemic and haematological agents	0.001	0.998	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.001	0.998	0.000
T45.6 Fibrinolysis-affecting drugs	0.001	0.998	0.000
T45.4 Iron and its compounds	0.001	0.998	0.000
T45.3 Enzymes, not elsewhere classified	0.001	0.998	0.000
T45.2 Vitamins, not elsewhere classified	0.001	0.998	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.001	0.998	0.000
G80.9 Infantile cerebral palsy, unspecified	0.001	0.998	0.000
O71.8 Other specified obstetric trauma	0.001	0.998	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.001	0.998	0.000
V18.0 Driver injured in nontraffic accident	0.001	0.998	0.000
C95.9 Leukaemia, unspecified	0.000	0.999	0.001
T38.9 Other and unspecified hormone antagonists	0.001	0.999	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.001	0.999	0.000
T38.7 Androgens and anabolic congeners	0.001	0.999	0.000
T38.5 Other oestrogens and progestogens	0.001	0.999	0.000
T38.4 Oral contraceptives	0.001	0.999	0.000
T38.2 Antithyroid drugs	0.001	0.999	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.001	0.999	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.001	0.999	0.000
T46.7 Peripheral vasodilators	0.001	0.999	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.001	0.999	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.001	0.999	0.000
T91.5 Sequelae of injury of intra-abdominal and pelvic organs	0.001	0.999	0.000
T91.4 Sequelae of injury of intrathoracic organs	0.001	0.999	0.000
T91.0 Sequelae of superficial injury and open wound of neck and trunk	0.001	0.999	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.001	0.999	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.001	0.999	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.001	0.999	0.000
C67.4 Posterior wall of bladder	0.000	0.999	0.001
M86.9 Osteomyelitis, unspecified	0.000	0.999	0.001
T39.4 Antirheumatics, not elsewhere classified	0.001	0.999	0.000
T39.2 Pyrazolone derivatives	0.001	0.999	0.000
O16 Unspecified maternal hypertension	0.000	0.999	0.001
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.001	0.999	0.000
S06.01 Concussion (with open intracranial wound)	0.001	0.999	0.000
G82.2 Paraplegia, unspecified	0.001	0.999	0.000
G83.9 Paralytic syndrome, unspecified	0.001	0.999	0.000
C67.1 Dome of bladder	0.000	0.999	0.001
D17.7 Benign lipomatous neoplasm of other sites	0.001	0.999	0.000
D23.1 Skin of eyelid, including canthus	0.000	0.999	0.001
H72.8 Other perforations of tympanic membrane	0.001	0.999	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.001	0.999	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.001	0.999	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.001	0.999	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.001	0.999	0.000
T47.7 Emetics	0.001	0.999	0.000
T47.6 Antidiarrhoeal drugs	0.001	0.999	0.000
T47.5 Digestants	0.001	0.999	0.000
T47.4 Other laxatives	0.001	0.999	0.000
T47.3 Saline and osmotic laxatives	0.001	0.999	0.000
T47.2 Stimulant laxatives	0.001	0.999	0.000
T47.0 Histamine H(2)-receptor antagonists	0.001	0.999	0.000
H72 Perforation of tympanic membrane	0.001	0.999	0.000
L12.0 Bullous pemphigoid	0.001	0.999	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.001	0.999	0.000
T91.8 Sequelae of other specified injuries of neck and trunk	0.001	0.999	0.000
B44.9 Aspergillosis, unspecified	0.001	0.999	0.000
H72.2 Other marginal perforations of tympanic membrane	0.001	0.999	0.000
V17.0 Driver injured in nontraffic accident	0.001	0.999	0.000
M96.65 Fracture of pelvis following insertion of orthopedic implant, joint prosthesis, or bone plate (Fx pelvis following insrt ortho implnt/prosth/bone plt)	0.001	0.999	0.000
M96.63 Fracture of radius or ulna following insertion of orthopedic implant, joint prosthesis, or bone plate	0.001	0.999	0.000
C67.2 Lateral wall of bladder	0.000	0.999	0.001
T50.6 Antidotes and chelating agents, not elsewhere classified	0.001	0.999	0.000
T93.9 Sequelae of unspecified injury of lower limb	0.001	0.999	0.000
X41 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.001	0.999	0.000
M25.56 Pain in joint (Lower leg)	0.001	0.999	0.000
M86.95 Osteomyelitis, unspecified (Pelvic region and thigh)	0.000	0.999	0.001
S32.10 Fracture of sacrum (closed)	0.001	0.999	0.000
G11.9 Hereditary ataxia, unspecified	0.000	0.999	0.001
O71.7 Obstetric haematoma of pelvis	0.001	0.999	0.000
T41.5 Therapeutic gases	0.001	0.999	0.000
T41.4 Anaesthetic, unspecified	0.001	0.999	0.000
T41.3 Local anaesthetics	0.001	0.999	0.000
T41.2 Other and unspecified general anaesthetics	0.001	0.999	0.000
T41.1 Intravenous anaesthetics	0.001	0.999	0.000
T41.0 Inhaled anaesthetics	0.001	0.999	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.001	0.999	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.001	0.999	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.001	0.999	0.000
T48.5 Anti-common-cold drugs	0.001	0.999	0.000
T48.4 Expectorants	0.001	0.999	0.000
T48.3 Antitussives	0.001	0.999	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.001	0.999	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.001	0.999	0.000
T48.0 Oxytocic drugs	0.001	0.999	0.000
T49.9 Topical agent, unspecified	0.001	0.999	0.000
T49.8 Other topical agents	0.001	0.999	0.000
T49.7 Dental drugs, topically applied	0.001	0.999	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.001	0.999	0.000
T49.5 Ophthalmological drugs and preparations	0.001	0.999	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.001	0.999	0.000
T49.3 Emollients, demulcents and protectants	0.001	0.999	0.000
T49.2 Local astringents and local detergents	0.001	0.999	0.000
T49.1 Antipruritics	0.001	0.999	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.001	0.999	0.000
T50.4 Drugs affecting uric acid metabolism	0.001	0.999	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.001	0.999	0.000
Z01.7 Laboratory examination	0.001	0.999	0.000
Y73 Gastro-enterology and urology devices associated with adverse incidents	0.001	0.999	0.000
M86.93 Osteomyelitis, unspecified (Forearm)	0.000	0.999	0.001
M86.92 Osteomyelitis, unspecified (Upper arm)	0.000	0.999	0.001
M86.91 Osteomyelitis, unspecified (Shoulder region)	0.000	0.999	0.001
M86.90 Osteomyelitis, unspecified (Multiple sites)	0.000	0.999	0.001
C17.9 Small intestine, unspecified	0.000	0.999	0.001
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.001	0.999	0.000
T45.5 Anticoagulants	0.001	0.999	0.000
T50.7 Analeptics and opioid receptor antagonists	0.001	0.999	0.000
T50.5 Appetite depressants	0.001	0.999	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.001	0.999	0.000
T50.1 Loop [high-ceiling] diuretics	0.001	0.999	0.000
T50.0 Mineralocorticoids and their antagonists	0.001	0.999	0.000
M96.9 Postprocedural musculoskeletal disorder, unspecified	0.001	0.999	0.000
S32.4 Fracture of acetabulum	0.001	0.999	0.000
M86.98 Osteomyelitis, unspecified (Other)	0.000	0.999	0.001
C83.3 Large cell (diffuse)	0.000	0.999	0.001
H49.0 Third [oculomotor] nerve palsy	0.000	0.999	0.001
S99.9 Unspecified injury of ankle and foot	0.001	0.999	0.001
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.001	0.999	0.000
T37.5 Antiviral drugs	0.001	0.999	0.000
T37.4 Anthelminthics	0.001	0.999	0.000
T37.3 Other antiprotozoal drugs	0.001	0.999	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.001	0.999	0.000
T37.1 Antimycobacterial drugs	0.001	0.999	0.000
T37.0 Sulphonamides	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations